STOCK TITAN

LifeStance director Burdick sells 159,624 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

LifeStance Health Group, Inc. (LFST) director Kenneth A. Burdick exercised options covering 2,999,997 shares at a $7.61 exercise price on November 12, 2026, and reported selling 159,624 common shares at a weighted average of $14.31 per share. The sales were made in multiple transactions ranging from $14.300 to $14.375.

The issuer withheld 2,148,328 shares for tax withholding obligations and payment of the exercise price. The footnote says this reduced shares issued on settlement of vested RSUs and did not constitute an open-market sale. The option row reports 59,849 shares following the transaction. A separate holding entry lists 46,511 shares held indirectly through Burdick Family LLC.

Insider Burdick Kenneth A
Role Director
Sold 159,624 shs ($2.28M)
Approx. gross sale proceeds $2.28M
Approx. exercise cost $22.83M
Type Security Shares Price Value
Exercise Stock Option (right to buy) F3 2,999,997 $0.00 $0.00
Sale Common Stock F1 159,624 $14.31 $2.28M
Exercise Common Stock 2,999,997 $7.61 $22.83M
Exercise Price or Tax Liability Common Stock F2 2,148,328 $14.31 $30.74M
Holding Common Stock -- -- --
Holdings After Transaction: Stock Option (right to buy) — 59,849 options (Direct); Common Stock — 3,596,266 shares (Direct); Common Stock — 46,511 shares (Indirect, By Burdick Family LLC)
Footnotes (3)
  1. F1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.300 to $14.375 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  2. F2. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations and for payment of the exercise price in connection with the exercise of stock options. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
  3. F3. Includes an option to purchase 3,059,864 shares of the Issuer's common stock, subject to time-based vesting (the "Time-Vesting Option"). The Time-Vesting Option vested as to 25% on each of the first four anniversaries of the vesting commencement date, September 7, 2022.
Shares covered by options exercised 2,999,997 shares Exercise reported November 12, 2026
Exercise price $7.61 per share Options exercised November 12, 2026
Common shares sold 159,624 shares Sale reported November 12, 2026
Weighted average sale price $14.31 per share Sales reported November 12, 2026
Sale price range $14.300 to $14.375 per share Multiple sale transactions; range is inclusive
Shares withheld for tax obligations and exercise-price payment 2,148,328 shares In connection with the option exercise; footnote says withholding reduced shares issued upon settlement of vested RSUs
Shares following option transaction 59,849 shares Reported following the November 12, 2026 transaction
Indirect shares held through Burdick Family LLC 46,511 shares Reported holding on November 12, 2026
weighted average price financial
"The price reported is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
time-based vesting financial
"subject to time-based vesting"
Time-based vesting is a schedule that gives employees or contractors ownership of granted stock or options gradually as they remain with a company, like unlocking rewards in a loyalty program the longer you stick around. For investors, it matters because it affects future share supply, management incentives and staff retention — all of which can influence company performance and dilution of existing shareholders.
vested RSUs financial
"settlement of vested RSUs"
exercise price financial
"for payment of the exercise price in connection with the exercise"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LFST shares did director Kenneth A. Burdick sell, and at what price?

Kenneth A. Burdick reported selling 159,624 common shares on November 12, 2026, at a weighted average price of $14.31 per share. The sales were made in multiple transactions ranging from $14.300 to $14.375 inclusive. No Rule 10b5-1 plan is reported.

How many LFST options did Kenneth A. Burdick exercise, and at what price?

Kenneth A. Burdick exercised options covering 2,999,997 LifeStance common shares at a $7.61 exercise price on November 12, 2026. The option row reports 59,849 shares following the transaction. The footnote says the referenced time-based option vested 25% on each of the first four anniversaries of September 7, 2022.

Why were LFST shares withheld in connection with Kenneth A. Burdick’s option exercise?

The issuer withheld 2,148,328 shares for tax withholding obligations and payment of the exercise price. The footnote says the withholding reduced shares issued upon settlement of vested RSUs and did not constitute an open-market sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Burdick Kenneth A

(Last)(First)(Middle)
C/O LIFESTANCE HEALTH GROUP, INC.
4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)
SCOTTSDALE ARIZONA 85251

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/12/2026S159,624(1)D$14.312,774,597D
Common Stock11/12/2026M2,999,997A$7.615,744,594D
Common Stock11/12/2026F2,148,328(2)D$14.313,596,266D
Common Stock46,511IBy Burdick Family LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$7.6111/12/2026M2,999,997 (3)09/07/2032Common Stock2,999,997$0.0059,849D
Explanation of Responses:
1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.300 to $14.375 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
2. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations and for payment of the exercise price in connection with the exercise of stock options. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
3. Includes an option to purchase 3,059,864 shares of the Issuer's common stock, subject to time-based vesting (the "Time-Vesting Option"). The Time-Vesting Option vested as to 25% on each of the first four anniversaries of the vesting commencement date, September 7, 2022.
By: /s/ Ryan Pardo, Attorney-in-Fact11/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading